Skip to content

The Neural Correlates of Food Choice Decision-making in Obesity and Weight Loss

The Neural Correlates of Food Choice Decision-making in Obesity and Weight Loss (CHOICES)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01218503
Acronym
CHOICES
Enrollment
90
Registered
2010-10-11
Start date
2010-03-31
Completion date
2016-10-31
Last updated
2013-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Weight Control, Weight Loss

Brief summary

This study is designed to determine whether obese, normal weight, and successful weight loss maintainers differ in their food choice decision-making and/or executive function, and whether participation in a behavioral weight loss program leads to neural and/or behavioral changes. The investigators will examine behavioral performance on several tasks involving decision-making and self-control in conjunction with brain imaging data acquired during a food-choice decision-making task. Participants enrolled in the behavioral weight loss program will also be assessed following the treatment.

Interventions

BEHAVIORALCHOICES - obese

Standard group behavioral weight loss treatment

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
California Institute of Technology
CollaboratorOTHER
The Miriam Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
35 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* women, ages 35-55, who are either currently obese (BMI = 30-40 kg/m2), always normal weight (lifetime BMI \< 25, NW) or successful weight loss maintainers who have lost 10% of their body weight and maintained that loss for at least 1 year (lifetime maximum BMI = 30-40 kg/m2)

Exclusion criteria

* weight loss medications, binge eating, standard MRI contraindications (e.g., metal implants, claustrophobia, pregnancy), left-handedness, food allergies, neurological or psychiatric conditions, including but not limited to schizophrenia, bipolar disorder, epilepsy, stroke and traumatic brain injury with loss of consciousness, and, among obese participants, inability to participate at two time points and lack of interest in participating in a behavioral weight loss trial * serious current physical disease (e.g., heart disease and cancer) for which physician supervision of diet and exercise prescription is needed, physical problems that limit the ability to exercise, participation in a weight loss program in the last 2 months and intention to become pregnant in the next 6 months

Design outcomes

Primary

MeasureTime frame
fMRIpre- and post-treatment in obese group, single time point for SWLM and NW

Secondary

MeasureTime frame
Behavioral datapre- and post-treatment of obese group, single time point for SWLM and NW

Countries

United States

Contacts

Primary ContactKathryn E Demos, PhD
kathryn_demos@brown.edu401-793-8939

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026